Home LiteratureArticle Details
PMID: 12610564 Published · ppublish English Comment Letter

Choosing CCR5 or Rev siRNA in HIV-1.

Nature biotechnology ·Vol. 21 ·No. 3 ·2003-03-00 ·Pages 230-1

Arteaga HJ, Hinkula J, van Dijk-Härd I, Dilber MS, Wahren B, Christensson B, Mohamed AJ, Smith CI

Abstract

暂无摘要

MeSH Terms
Cell Line Gene Products, rev/metabolism HIV Reverse Transcriptase/metabolism HIV-1/drug effects,enzymology,genetics,growth & development Monocytes/virology RNA, Double-Stranded/genetics,metabolism,pharmacology RNA, Small Interfering/genetics,metabolism,pharmacology RNA, Untranslated/genetics,metabolism,pharmacology RNA, Viral/genetics,metabolism Receptors, CCR5/drug effects,metabolism Transfection Virus Replication/drug effects rev Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, rev RNA, Double-Stranded RNA, Small Interfering RNA, Untranslated RNA, Viral Receptors, CCR5 rev Gene Products, Human Immunodeficiency Virus HIV Reverse Transcriptase
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Arteaga H Jose
Hinkula Jorma
van Dijk-Härd Iris
Dilber M Sirac
Wahren Britta
Christensson Birger
Mohamed Abdalla J
Smith C I Edvard
Article Info
Journal
Nature biotechnology
Abbr.
Nat Biotechnol
ISSN
1087-0156
Published
2003-03-00
Pages
230-1
Language
English
Region
United States
NLM ID
9604648
Subset
IM
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com